S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NASDAQ:YMTX

Yumanity Therapeutics - YMTX Earnings Date, Estimates & Call Transcripts

$3.19
+0.03 (+0.95%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.11
▼
$3.49
50-Day Range
$3.16
▼
$8.33
52-Week Range
$0.95
▼
$13.23
Volume
9,693 shs
Average Volume
473,083 shs
Market Capitalization
$34.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

YMTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

YMTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Yumanity Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($1.27)($1.27)($1.27)
Q2 20231($1.33)($1.33)($1.33)
Q3 20231($1.36)($1.36)($1.36)

Yumanity Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/4/2022Q2 2022($1.13)($0.45)+$0.68($0.45)$1.66 million
5/12/2022Q1 2022($1.02)($1.24)($0.22)($1.24)$1.50 million$1.02 million
3/24/2022Q4 2021($1.00)($1.00)($1.00)$1.81 million$0.76 million
11/15/2021Q3 2021($1.13)($0.97)+$0.16($0.97)$1.93 million$1.64 million
8/12/20216/30/2021($0.84)($1.03)($0.19)($1.03)$2.27 million$2.11 million
5/13/20213/31/2021($0.84)($0.85)($0.01)($0.85)$1.00 million$3.53 million
11/16/2020Q3 2020($3.40)($3.20)+$0.20($3.20)
8/6/2020Q2 2020($4.20)($3.40)+$0.80($3.40)
5/15/2020Q1 2020($4.60)($3.80)+$0.80($3.80)
3/10/2020Q4 2019($5.80)($4.60)+$1.20($4.60)
11/7/2019Q3 2019($8.00)($5.00)+$3.00($5.00)
8/7/2019Q2 2019($7.00)($7.80)($0.80)($7.80)
5/8/2019Q1 2019($8.60)($5.60)+$3.00($5.60)$0.80 million$5.00 million
3/8/2019Q4 2018($9.20)($7.20)+$2.00($7.20)
11/6/2018Q3 2018($9.20)($10.00)($0.80)($10.00)$0.83 million$1.06 million
8/8/2018Q2 2018($8.20)($8.60)($0.40)($8.60)$1.16 million$0.84 million
5/9/2018Q1 2018($10.20)($6.40)+$3.80($6.40)$1.03 million$0.94 million
3/14/2018Q4 2017($13.00)($10.20)+$2.80($10.20)$1.58 million$1.62 million
11/14/2017Q3 2017($12.60)($11.20)+$1.40($11.20)$1.38 million$1.55 million
8/4/2017Q2 2017($12.20)($13.60)($1.40)($13.60)$1.09 million$1.15 million
5/12/2017Q1 2017($11.60)($12.00)($0.40)($12.00)$1.02 million
3/30/2017Q4 2016($10.20)($7.60)+$2.60($7.60)$1.71 million$4.06 million
11/10/2016Q3 2016($10.00)($10.80)($0.80)($10.80)$1.72 million
8/15/2016Q2 2016($8.20)($9.40)($1.20)($9.40)$1.45 million
5/13/2016Q1 2016($9.40)($17.40)($8.00)($17.40)$2.44 million$1.16 million












Yumanity Therapeutics Earnings - Frequently Asked Questions

How much revenue does Yumanity Therapeutics generate each year?

Yumanity Therapeutics (NASDAQ:YMTX) has a recorded annual revenue of $4.84 million.

How much profit does Yumanity Therapeutics generate each year?

Yumanity Therapeutics (NASDAQ:YMTX) has a recorded net income of -$39.50 million. YMTX has generated -$3.00 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:YMTX) was last updated on 3/28/2023 by MarketBeat.com Staff